News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,106 Results
Type
Article (5104)
Company Profile (25)
Press Release (226977)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82266)
Career Advice (463)
Deals (15065)
Drug Delivery (8)
Drug Development (19108)
Employer Resources (30)
FDA (3685)
Job Trends (3910)
News (120230)
Policy (7519)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14813)
ALS (38)
Alzheimer's disease (296)
Antibody-drug conjugate (ADC) (41)
Approvals (3785)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2866)
Biosimilars (32)
Biotechnology (24)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (887)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16708)
Collaboration (354)
Compensation (371)
Complete response letters (8)
COVID-19 (315)
CRISPR (13)
C-suite (338)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2114)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42746)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39163)
Executive appointments (427)
FDA (4423)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (145)
Government (423)
Guidances (197)
Healthcare (5045)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (341)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7890)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3918)
Medtech (3928)
Mergers & acquisitions (7580)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (541)
NextGen: Class of 2026 (1675)
Non-profit (730)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (27)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25224)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5005)
Phase 2 (7241)
Phase 3 (5802)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1946)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5542)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (14)
Tariffs (7)
The Weekly (1)
Vaccines (81)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Last 7 days (146)
Last 30 days (538)
Last 365 days (8886)
2026 (784)
2025 (9039)
2024 (11035)
2023 (13198)
2022 (18667)
2021 (19709)
2020 (18265)
2019 (13217)
2018 (10208)
2017 (10001)
2016 (9158)
2015 (12119)
2014 (9588)
2013 (7709)
2012 (8329)
2011 (8796)
2010 (8636)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11787)
Australia (1691)
California (3542)
Canada (1138)
China (168)
Colorado (143)
Connecticut (163)
Delaware (70)
Europe (25491)
Florida (541)
Georgia (68)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (19)
New Jersey (1018)
New Mexico (5)
New York (815)
North Carolina (479)
North Dakota (4)
Northern California (1855)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (480)
United States (12334)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,106 Results for "bioxcel corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
January 12, 2026
·
11 min read
Press Releases
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
January 7, 2026
·
9 min read
Press Releases
BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting
January 20, 2026
·
11 min read
Press Releases
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
September 18, 2025
·
6 min read
Press Releases
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
October 15, 2025
·
8 min read
Press Releases
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
November 13, 2025
·
17 min read
Press Releases
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 4, 2025
·
5 min read
Press Releases
BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference
August 12, 2025
·
5 min read
Press Releases
BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates
August 13, 2025
·
16 min read
Press Releases
BioXcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package in Support of Potential Label Expansion for IGALMI®
July 22, 2025
·
10 min read
1 of 23,211
Next
